.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Calcium acetate - Generic Drug Details

« Back to Dashboard
Calcium acetate is the generic ingredient in five branded drugs marketed by Cypress Pharm, Paddock Llc, Heritage Pharms Inc, Invagen Pharms, Lupin Ltd, West-ward Pharms Int, Amneal Pharms, Fresenius Medcl, Nostrum Labs Inc, and Eci Pharms Llc, and is included in sixteen NDAs. There are five patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

This ingredient has twenty-two patent family members in seventeen countries.

There are two hundred and fifty-nine drug master file entries for calcium acetate. Thirty suppliers are listed for this compound.

Summary for Generic Name: calcium acetate

Tradenames:5
Patents:5
Applicants:10
NDAs:16
Drug Master File Entries: see list259
Suppliers / Packagers: see list30
Bulk Api Vendors: see list28
Clinical Trials: see list1,149
Therapeutic Class:Genitourinary Agents
Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:calcium acetate at DailyMed

Pharmacology for Ingredient: calcium acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms
CALCIUM ACETATE
calcium acetate
TABLET;ORAL202420-001Feb 5, 2013RXNoNo► subscribe► subscribe
Heritage Pharms Inc
CALCIUM ACETATE
calcium acetate
TABLET;ORAL202885-001Jan 22, 2015RXNoNo► subscribe► subscribe
Fresenius Medcl
PHOSLO GELCAPS
calcium acetate
CAPSULE;ORAL021160-003Apr 2, 2001RXYesYes6,875,445► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: calcium acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fresenius Medcl
PHOSLO
calcium acetate
CAPSULE;ORAL021160-001Apr 2, 20014,870,105► subscribe
Fresenius Medcl
PHOSLO
calcium acetate
TABLET;ORAL019976-001Dec 10, 19904,870,105► subscribe
Fresenius Medcl
PHOSLO
calcium acetate
CAPSULE;ORAL021160-002Apr 2, 20014,870,105► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: calcium acetate

Country Document Number Estimated Expiration
Poland2048948► subscribe
China101522021► subscribe
South Korea101553719► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CALCIUM ACETATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2008006,C0933372Lithuania► subscribePRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
/1997Austria► subscribePRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107
C/GB03/033United Kingdom► subscribePRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc